Skip to main content
Premium Trial:

Request an Annual Quote

Correcting Itself, MWG Biotech Said It s Not Really Pfizer s Partner of Choice

NEW YORK, March 26 (GenomeWeb News) - MWG Biotech yesterday said it is not really a Pfizer 'Partner of Choice,' but instead is an 'Approved Supplier of the drug giant.

 

MWG issued a statement yesterday correcting a press release it issued on Wednesday claiming it is a 'Partner of Choice' after penning a sales and services contract for sequencing, microarrays, and oligonucleotides.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.